Geron trial resumes, but standards for stem cell trials remain elusive.
Creator
Strauss, Stephen
Bibliographic Citation
Nature biotechnology 2010 Oct; 28(10): 989-90
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
University Foundation Says Geron May Lose Stem-Cell Rights
Pollack, Andrew (2001-11-02) -
Geron Keeps Some Stem-Cell Rights
Gillis, Justin (2002-01-10) -
Another Stem Cell Debate: Ethics Aside, a Good Business Model Remains Elusive
Pollack, Andrew (2001-07-28)